# Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery

> **NCT02997553** · PHASE3 · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 744 (actual)

## Conditions studied

- Breast Carcinoma
- Head and Neck Cancer
- Melanoma (Skin)
- Squamous Cell Carcinoma, Skin
- Cervix Cancer
- Endometrium Cancer
- Ovary Cancer
- Vulva Cancer
- Anus Cancer
- Rectum Cancer

## Interventions

- **DRUG:** Indocyanine green
- **DRUG:** Technetium99
- **DEVICE:** Optonuclear probe
- **DEVICE:** Quest Camera

## Key facts

- **NCT ID:** NCT02997553
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2022-09-19
- **Final completion:** 2022-10-12
- **Target enrollment:** 744 (ACTUAL)
- **Last updated:** 2023-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02997553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02997553, "Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02997553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*